| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 7 Feb 2026 | 2 Feb 2026 |
| Tejnaksh Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2026 ,inter alia, to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, We hereby inform you that a meeting of the Board of Directors of the Company will be held on Saturday, 07th February, 2026 at Shop No 1 Building Name:Shivprasad Harihar Singh Compound, Block Sector:Jogeshwari East, Road: Caves Road. Pratap Nagar -Mumbai, Maharashtra, 400060to transact the business as given below: 1. To Consider and approve Un-Audited Financial Results (Standalone & Consolidated) for the Quarter 31st December 2025. 2. Any other matter with the permission of the Chair In continuation of our Letter dated 2th February, 2026 we wish to inform you that a meeting of the Board of Directors of the Company was held on Saturday, 7th February, 2026 at Shop No 1 Building Name: Shivprasad Harihar Singh Compound, Block Sector: Jogeshwari East, Road: Caves Road. Pratap Nagar -Mumbai, Maharashtra, 400060 to at 4.00 pm. and has transacted the following: - 1. Considered and approved Un-Audited Financial Results (Standalone & Consolidated) for the quarter ended on 31th December 2025 and took note of Limited Review Report thereon, in terms of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015; The meeting of Board of Directors commenced at 4:00 pm and concluded at 6.00 pm This is for your information and record. Please refer standalone and consolidated unaudited result for the quarter ended 31st December 2025. (As Per BSE Announcement Dated on:07.02.2026) | ||
| Board Meeting | 8 Nov 2025 | 2 Nov 2025 |
| Tejnaksh Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2025 inter alia to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 We hereby inform you that a meeting of the Board of Directors of the Company will be held on Saturday 08th November 2025 at Shop No 1 Building Name:Shivprasad Harihar Singh Compound Block Sector:Jogeshwari East Road: Caves Road. Pratap Nagar -Mumbai Maharashtra 400060to transact the business as given below: 1. To Consider and approve Un-Audited Financial Results (Standalone & Consolidated) for the Quarter 30th September 2025. 2. Any other matter with the permission of the Chair. In continuation of our Letter dated 1st November, 2025 we wish to inform you that a meeting of the Board of Directors of the Company was held on Saturday, 8th November, 2025 at Shop No 1 Building Name:Shivprasad Harihar Singh Compound, Block Sector:Jogeshwari East, Road: Caves Road. Pratap Nagar -Mumbai, Maharashtra, 400060 to at 5.00 p.m. and has transacted the following: - 1. Considered and approved Un-Audited Financial Results (Standalone & Consolidated) for the quarter ended on 30th September 2025 and took note of Limited Review Report thereon, in terms of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015; The meeting of Board of Directors commenced at 5.00 p.m. and concluded at 10.00 pm. Please find enclosed financial result for the quarter ended 30th September 2025 (As Per BSE Announcement Dated on:08.11.2025) | ||
| Board Meeting | 14 Aug 2025 | 6 Aug 2025 |
| Tejnaksh Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2025 inter alia to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 We hereby inform you that a meeting of the Board of Directors of the Company will be held on Thursday 14th August 2025 at Shop No 1 Building Name:Shivprasad Harihar Singh Compound Block Sector:Jogeshwari East Road: Caves Road. Pratap Nagar -Mumbai Maharashtra 400060to transact the business as given below: 1. To Consider and approve Un-Audited Financial Results (Standalone & Consolidated) for the Quarter 30th June 2025. 2. Any other matter with the permission of the Chair. Further in terms of the Provision of the SEBI (Prohibition of Insider Trading) Regulation 2015 and in compliance of the circular no. LIST/COMP/ 01/2019-20 issued by BSE Limited on 02ndApril 2019 intimation for the closure of trading window of the company for dealing in the shares of the Company was given vide intimation letter dated 26th June 2025 till expiry of 48 hours after the declaration of Un-audited In continuation of our Letter dated 06th August, 2025 we wish to inform you that a meeting of the Board of Directors of the Company was held on Thursday, 14th August, 2025 at Shop No 1 Building Name: Shivprasad Harihar Singh Compound, Block Sector: Jogeshwari East, Road: Caves Road. Pratap Nagar -Mumbai, Maharashtra, 400060 at 3.00 pm and has transacted the following: - 1. Considered and approved Un-Audited Financial Results (Standalone & Consolidated) for the quarter ended on 30th June 2025 and took note of Limited Review Report thereon, in terms of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015; The meeting of Board of Directors commenced at 3:00 pm and concluded at 7.00 pm (As Per BSE Announcement Dated on: 14/08/2025 | ||
| Board Meeting | 29 May 2025 | 23 May 2025 |
| Tejnaksh Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 inter alia to consider and approve 1.Audited Financial Results (Standalone & Consolidated) for the Quarter and year ended March 31 2025; 2. Any other matter with the permission of the Chair We wish to inform you that the meeting of the Board of Directors of the Company held Today i.e. Thursday, May 29, 2025 1..Considered and approved Audited Financial Results (Standalone & Consolidated) for the quarter and Year ended on March 31, 2025 and Auditors Report thereon, in terms of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015; 2. A declaration pursuant to Regulation 33(3)(d) of the SEBI (LODR) Regulations, 2015, regarding unmodified opinion of the Statutory Auditors on the annual financial results for the financial year ended March 31, 2025. 3. Consider and approved the Change in registered office of the Company within the local limits of city where the registered office of the Company is presently situated Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, The meeting of Board of Directors commenced at 06:00pm and concluded at 10 pm (As per BSE Announcement Dated on 29/05/2025) | ||
| Board Meeting | 15 Apr 2025 | 7 Apr 2025 |
| Tejnaksh Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/04/2025 ,inter alia, to consider and approve In compliance with Regulation 29(1)(d) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Meeting of the Board of Directors of the company is scheduled to be held on Saturday, April 12, 2025 to discuss the following agenda, including but not limited to: 1. To consider, take on record and approve the Draft Letter of Offer in relation to the proposed Right Issue of Equity Shares by the Company. 2. To Consider Change in Registered o??ice of the company within the local limits of same Town & City. 3. Any other matter with permission of Chairman of the meeting. Tejnaksh Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/04/2025 ,inter alia, to consider and approve We wish to inform you that the Meeting of the Board of Directors of the company was schedule to be held on Saturday, April 12, 2025 postponed to Tuesday, 15th April 2025 to discuss the following agenda, including but not limited to: 1. To consider, take on record and approve the Draft Letter of Offer in relation to the proposed Right Issue of Equity Shares by the Company. (As Per Bse Announcement Dated on 12.04.2025) In continuation of earlier intimation dated April 9, 2025, in compliance with Regulation 29(1)(d) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it was informed that the Meeting of the Board of Directors of the company is scheduled to be held on Tuesday, April 15, 2025 to discuss, inter alia, the Draft Letter of Offer in relation to the proposed Right Issue of Equity Shares by the Company, we have to inform that the Board after careful consideration of the draft letter offer for the proposed rights issue upto Rs. 725 lakhs and matters incidental or consequential thereto, approved the draft letter and authorized its filing on-line with BSE for their approval, the designated Stock Exchange as per applicable provisions of SEBI ICDR, 2018. (As Per Bse Announcement Dated on 15.04.2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
